Recent Appellate Decisions Suggest Significant Limits on the Use Of the False Claims Act to Police Alleged Violations of FDA Regulations

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know

In House Warrior with Daniel Kracov